Chronic myeloid leukemia (CML) is a type of blood cancer. CML is Philadelphia chromosome-positive (Ph+) when pieces of chromosomes 9 and 22 break off and swap places. This creates a new abnormal ...

PRINCETON, N.J. & WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced a charitable donation to The Leukemia & Lymphoma Society (LLS). The donation will provide ...

IP ratings identify the level of protection equipment has to withstand ingress, from environmental factors such as rain and dust particles, and foreign objects such as wires and tools. As well as the ...

Australian researchers have made a world-first breakthrough in the early detection of patients' resistance to a common treatment for chronic myeloid leukemia. The discovery offers some hope that the ...

CML is traditionally regarded as a paradigm of precision medicine, under several points of view: 1) it is the first human malignancy whose molecular pathogenesis was unravelled, well before the advent ...

When it comes to selecting a cost-effective, first-line tyrosine kinase inhibitor (TKI) for the treatment of chronic myeloid leukemia (CML), consider the treatment goal. For survival, generic imatinib ...

Exactly three years after an initial FDA green light for the third-line treatment of leukemia, Novartis’ Scemblix has won an accelerated approval to treat newly diagnosed patients. Tuesday, the FDA ...